Deflazacort or Prednisone Treatment for Duchenne Muscular Dystrophy: A Meta-analysis of Disease Progression Rates in Two Multicenter Clinical Trials

被引：0
|
作者：
Signorovitch, J.
Sajeev, G.
Yao, Z.
McDonnell, E.
Elfring, G.
Trifillis, P.
Souza, M.
Speltz, S.
Darras, B.
Shieh, P.
McDonald, C.
机构：
来源：
ANNALS OF NEUROLOGY | 2019年 / 86卷
关键词：
Neuromuscular Disorders; Rare Diseases;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
189
引用
收藏
页码：S128 / S129
页数：2
相关论文
共 50 条
  • [1] DEFLAZACORT OR PREDNISONE TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY: A META-ANALYSIS OF DISEASE PROGRESSION RATES IN TWO MULTICENTER CLINICAL TRIALS
    Signorovitch, James
    Sajeev, Gautam
    Yao, Zhiwen
    McDonnell, Erin
    Elfring, Gary
    Trifillis, Panayiota
    Souza, Marcia
    Peltz, Stuart
    Darras, Basil
    Shieh, Perry B.
    McDonald, Craig
    MUSCLE & NERVE, 2019, 60 : S13 - S13
  • [2] DEFLAZACORT OR PREDNISONE TREATMENT FOR DUCHENNE MUSCULAR DYSTROPHY: A META-ANALYSIS OF DISEASE PROGRESSION RATES IN RECENT MULTICENTER CLINICAL TRIALS
    Signorovitch, J. E.
    Sajeev, G.
    McDonnell, E.
    Yao, Z.
    VALUE IN HEALTH, 2017, 20 (09) : A718 - A718
  • [3] Deflazacort vs prednisone treatment for Duchenne muscular dystrophy: a meta-analysis of disease progression rates in recent multicenter clinical trials
    McDonald, Craig M.
    Sajeev, Gautam
    Yao, Zhiwen
    McDonnell, Erin
    Elfring, Gary
    Souza, Marcio
    Peltz, Stuart W.
    Darras, Basil T.
    Shieh, Perry B.
    Cox, David A.
    Landry, John
    Signorovitch, James
    MUSCLE & NERVE, 2020, 61 (01) : 26 - 35
  • [4] Deflazacort or Prednisone Treatment for Duchenne muscular Dystrophy: A Mete-Analysis of Disease Progression Rates in Recent Multicenter Clinical Trials
    Signorovitch, James
    Schilling, Traci
    Sajeev, Gautam
    Yao, Zhiwen
    McDonnell, Erin
    Elfring, Gary
    Souza, Marcio
    Peltz, Stuart
    Darras, Basil
    Shieh, Perry
    McDonald, Craig
    NEUROLOGY, 2019, 92 (15)
  • [5] Meta-Analysis of Deflazacort vs Prednisone/Prednisolone in Patients with Duchenne Muscular Dystrophy
    Darras, Basil
    Riebling, Peter
    O'Mara, Edward
    Elfring, Gary
    Luo, Xiaohui
    Trifillis, Panayiota
    McIntosh, Joseph
    Santos, Claudio
    Parsons, Julie
    Shieh, Perry B.
    Apkon, Susan
    Campbell, Craig
    McDonald, Craig
    NEUROLOGY, 2018, 90
  • [6] Effect of deflazacort and prednisone on muscle enzymes in the treatment of Duchenne muscular dystrophy
    Dubow, J.
    Cunniff, T.
    Wanaski, S.
    Meyer, J.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S180 - S180
  • [7] Effect of Deflazacort and Prednisone on Muscle Enzymes in the Treatment of Duchenne Muscular Dystrophy
    Dubow, Jordan
    Wanaski, Stephen
    Cunniff, Timothy
    Meyer, James
    NEUROLOGY, 2016, 86
  • [8] Associations between deflazacort vs prednisone/prednisolone and disease progression markers in subgroups of patients with Duchenne muscular dystrophy
    McDonald, C.
    Wing, J.
    Powell, A.
    Mastrandrea, N.
    Signorovitch, J.
    Marden, J.
    Lane, H.
    Zhang, A.
    Nguyen, H.
    ANNALS OF NEUROLOGY, 2022, 92 : S155 - S155
  • [9] A report of two deflazacort treatment protocols in Duchenne muscular dystrophy
    Biggar, WD
    Nigro, G
    Politano, L
    Harris, V
    Passamano, L
    Vajsar, J
    Alman, B
    Palladino, A
    DeLuca, F
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 630 - 630
  • [10] A multicenter, double-blind, randomized trial of deflazacort versus prednisone in Duchenne muscular dystrophy
    Bonifati, MD
    Ruzza, G
    Bonometto, P
    Berardinelli, A
    Gorni, K
    Orcesi, S
    Lanzi, G
    Angelini, C
    MUSCLE & NERVE, 2000, 23 (09) : 1344 - 1347
12345